Paul Grujic has 30 years experience in the Animal Health industry. He has worked for and alongside major Global and leading National Animal Health Companies including Glaxo, IMC, American Cyanamid, Wyeth, Pfizer and CSL. His roles have included R&D, Sales, Marketing, Business Development and General Management with at various times responsibility also for Export, Finance and Manufacturing in Australia, New Zealand and the USA. His experience incorporates acquisitions, mergers and integrations of large, medium and small organizations. He was previously a Director of Catapult Genetics
